Czech Republic challenges plasma award
The Czech Republic has applied to annul a US$650 million treaty award holding it liable for frustrating the investment of a blood plasma supplier and its owner, including through the state's actions in an earlier contractual arbitration, while revealing the investors had sought up to US$2.2 billion.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.